Physician profile
Jay D Patel
NPI 1639256696
$24,862.17
in general payments reported to CMS, 2019-2025
83 companies · $3,174 in 2025
The $3,174 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,877 · 2020: $2,292 · 2021: $5,623 · 2022: $4,444 · 2023: $2,951 · 2024: $3,501 · 2025: $3,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,625.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $3,561.91 | 2021-2025 | Opzelura |
| Abbvie INC. | $2,291.01 | 2019-2025 | |
| Novo Nordisk INC | $1,849.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $1,606.92 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $1,430.75 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,228.42 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $1,177.53 | 2019-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,009.28 | 2019-2025 | Jardiance, Spevigo, Tradjenta |
| Antares Pharma, INC. | $743.37 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Otsuka America Pharmaceutical, INC. | $626.99 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $613.83 | 2019-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $593.46 | 2019-2025 | Freestyle Libre 3, Aveir |
| Lilly USA, LLC | $523.54 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Amarin Pharma, INC. | $516.29 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $493.91 | 2022 |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $386.26 | 2020-2025 | Austedo Xr, Austedo Xr, Austedo |
| Lundbeck LLC | $333.10 | 2021-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $307.39 | 2019-2024 | Xarelto |
| Daiichi Sankyo INC. | $299.48 | 2020-2023 | Injectafer |
| Eisai INC. | $284.89 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $266.63 | 2021-2025 | Gardasil 9, Capvaxive, Belsomra |
| Kowa Pharmaceuticals America, INC. | $254.09 | 2019-2023 | Seglentis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $253.31 | 2022-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $218.36 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $215.19 | 2019-2025 | Trintellix |
| Allergan, INC. | $202.74 | 2019-2021 | |
| Dexcom, INC. | $175.38 | 2022-2025 | Dexcom G6 Transmitter |
| Collegium Pharmaceutical, INC. | $172.62 | 2021-2025 | Belbuca, Xtampza |
| Alkermes, INC. | $168.40 | 2022-2024 | Aristada, Lybalvi |
| Ibsa Pharma INC. | $160.09 | 2019-2025 | Licart, Flector, Tirosint |
| Ardelyx, INC. | $153.06 | 2024-2025 | Ibsrela |
| Astellas Pharma US INC | $148.06 | 2019-2025 | Veozah, Vesicare |
| Biohaven Pharmaceuticals, INC. | $146.12 | 2021 | |
| Phathom Pharmaceuticals, INC. | $144.51 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $140.79 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Scientific Affairs, LLC | $118.57 | 2024 | Tremfya |
| Axsome Therapeutics, INC. | $117.29 | 2023-2025 | Auvelity |
| Dova Pharmaceuticals | $116.75 | 2021 | |
| Novartis Pharmaceuticals Corporation | $109.99 | 2019-2023 | |
| Vanda Pharmaceuticals INC. | $107.74 | 2024-2025 | Fanapt |
| Almatica Pharma LLC | $105.74 | 2022-2024 | Loreev Xr, Teriparatide, Sertraline Hcl |
| Corium, LLC | $104.97 | 2023-2024 | Azstarys, Azstarys |
| Idorsia Pharmaceuticals US INC | $103.18 | 2022-2023 | Quviviq |
| Adlon Therapeutics L.P. | $96.35 | 2019-2021 | |
| Horizon Therapeutics Plc | $77.34 | 2020-2021 | |
| Harmony Biosciences LLC | $68.36 | 2024-2025 | |
| Currax Pharmaceuticals LLC | $67.31 | 2019-2023 | Onzetra Xsail, Nexletol, Nexlizet |
| Sanofi-Aventis U.S. LLC | $63.36 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $54.95 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $53.84 | 2020-2021 | |
| Alcon Vision LLC | $50.82 | 2023 | Clareon |
| Halozyme INC | $48.27 | 2023 | |
| Ironwood Pharmaceuticals, INC | $45.53 | 2022-2024 | |
| Verity Pharmaceuticals INC. | $45.31 | 2024-2025 | Tlando |
| Bausch Health US, LLC | $44.53 | 2021-2022 | |
| Vivus LLC | $38.32 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $36.40 | 2023-2024 | Dupixent |
| Corcept Therapeutics | $31.39 | 2025 | Korlym |
| Neos Therapeutics, Lp | $30.09 | 2024 | Adzenys Xr-Odt |
| Clarus Therapeutics INC. | $29.29 | 2021 | |
| Kaleo, INC. | $29.05 | 2020 | |
| Baxter Healthcare | $28.63 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Neotract INC. | $26.04 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $24.80 | 2020 | |
| Hikma Pharmaceuticals USA | $24.06 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $24.00 | 2020-2021 | |
| Edwards Lifesciences Corporation | $18.25 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Si-Bone, INC. | $17.04 | 2024 | |
| Ucb, INC. | $16.15 | 2022 | |
| Nevro Corp. | $15.99 | 2023 | Senza |
| Xeris Pharmaceuticals, INC. | $15.27 | 2023 | Gvoke Hypopen |
| Endo Pharmaceuticals INC. | $14.79 | 2020 | |
| Intra-Sana Laboratories | $14.61 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Metuchen Pharmaceuticals | $14.51 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $14.47 | 2019 | |
| Seqirus USA INC | $13.70 | 2019 | |
| Redhill Biopharma INC. | $13.20 | 2021 | |
| Sanofi Pasteur INC. | $13.20 | 2020 | |
| Fidia Pharma USA INC. | $12.98 | 2023 | Hymovis |
| Esperion Therapeutics, INC. | $12.93 | 2020 | |
| Genentech USA, INC. | $12.37 | 2022 | |
| Celgene Corporation | $11.91 | 2020 | |
| Gilead Sciences, INC. | $11.41 | 2020 |
Drugs and devices associated with these payments
Ozempic $620Nurtec Odt $618Rexulti $616Vraylar $531Rybelsus $528Zavzpret $488Evenity $408Jardiance $401Qulipta $399Ubrelvy $392Aristada $384Farxiga $356Wegovy $345Xyosted $306Breztri $282Freestyle Libre 3 $240Prolia $235Spevigo $221Kerendia $218Repatha $203Otezla $203Airsupra $196Xifaxan $180Trelegy Ellipta $176Lybalvi $167Mounjaro $166Tradjenta $163Austedo Xr $154Ibsrela $153Zepbound $151Dexcom G6 Transmitter $147Voquezna $145Xarelto $144Tremfya $119Veozah $118Aveir $118Auvelity $117Fanapt $108Azstarys $105Emgality $91.21Cologuard Collection Kit $86.70Tlando $86.30Belbuca $86.04Synjardy $82.52Comirnaty $82.44Paxlovid $78.97Quviviq $75.36Wakix $68.36Tirosint $65.45Arexvy $65.15Trijardy Xr $63.94Glyxambi $63.94Loreev Xr $62.50Eliquis $60.81Caplyta $55.40Rinvoq $55.27The Cologuard Plus Collection Kit $54.09Prevnar 20 $51.62Licart $50.93Clareon $50.82Gardasil 9 $50.53Abilify Maintena $49.81Austedo $49.21Trintellix $47.05Seglentis $46.31Nocdurna $40.99Abrysvo $38.97Opzelura $37.48Flector $36.41Dupixent $36.40Trulicity $34.39Capvaxive $34.22Belsomra $32.23Abilify Asimtufii $32.08Verquvo $31.74Teriparatide $31.41Korlym $31.39Shingrix $31.36Sertraline Hcl $31.09Adzenys Xr-Odt $30.09Hillrom - Carnation Ambulatory Monitor $28.63Calquence $27.97Vyndaqel $26.07Tzield $19.63Edwards Sapien 3 Ultra Transcatheter Heart Valve $18.25Linzess $17.88Xtampza $17.33Krystexxa $17.26Proquad $16.31Saxenda $16.04Entresto $16.02Leqvio $16.02Senza $15.99Ajovy $15.97Steglatro $15.87Gralise $15.67Vesicare $15.28Gvoke Hypopen $15.27Reltone 400 Mg $14.61Glycate $14.61
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.